Kathryn Beckermann, MD, PhD, discusses the patient-reported outcomes for tivozanib plus nivolumab from the phase 3 TiNivo-2 ...

Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

Eligibility issues, a need for better multidisciplinary collaboration, and a lack of incorporation in community practices are ...

Further assessment is needed to understand if these treatment recommendations were eventually adopted and if adoption leads to better outcomes,” researchers wrote.

J. Scott Cordova, M.D., Ph.D., has joined the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller ...

In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

Cancer patients face more than just the disease. They spend countless hours commuting, waiting, and undergoing treatment.

Katy Beckermann, MD, PhD, explained that oncology nurses and APPs should be ready to administer and explain dose modifications for patients with RCC.

NSAID use is associated with an increased risk of death from RCC among women but not among men, researchers found.